Pharmacy PEBC Practice Exam

When a patient is taking lithium, it is essential to monitor serum lithium levels and renal function due to the drug's narrow therapeutic index and potential for renal toxicity. Lithium is primarily eliminated through the kidneys, and any impairment in renal function can lead to elevated lithium levels in the body, which increases the risk of toxicity.

Monitoring serum lithium levels allows healthcare providers to ensure that the drug is within the therapeutic range, typically between 0.6 to 1.2 mEq/L for most indications. Levels above this range can result in side effects such as tremors, increased thirst, and in severe cases, can lead to lethal complications.

Additionally, renal function must be regularly assessed because reduced renal clearance can significantly affect lithium levels. Patients on long-term lithium therapy should have their kidney function evaluated periodically to prevent chronic complications like nephrogenic diabetes insipidus or acute kidney injury.

This emphasis on monitoring lithium levels and renal function is critical because it directly influences both the safety and efficacy of treatment, ensuring that the patient benefits from the medication while minimizing the risk of adverse effects.